Zebra Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $218K | Sell |
11,599
-3,019
| -21% | -$56.7K | 1.09% | 43 |
|
|
2022
Q4 | $233K | Buy |
14,618
+1,114
| +8% | +$17.8K | 0.82% | 47 |
|
|
2022
Q3 | $221K | Buy |
+13,504
| New | +$221K | 0.84% | 48 |
|
|
2022
Q2 | – | Sell |
-10,061
| Closed | -$244K | – | 99 |
|
|
2022
Q1 | $244K | Sell |
10,061
-9,973
| -50% | -$242K | 0.56% | 75 |
|
|
2021
Q4 | $468K | Sell |
20,034
-7,385
| -27% | -$173K | 0.75% | 44 |
|
|
2021
Q3 | $455K | Buy |
+27,419
| New | +$455K | 0.55% | 54 |
|